| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SMAD binding | 4.97e-05 | 86 | 47 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 1.93e-04 | 9 | 47 | 2 | GO:0017151 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.19e-04 | 562 | 47 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.36e-04 | 753 | 47 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.94e-04 | 582 | 47 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 6.26e-04 | 1271 | 47 | 10 | GO:0000987 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 7.21e-04 | 17 | 47 | 2 | GO:0070411 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | GLIS3 AUTS2 TFDP3 HOXB4 MYOCD CTBP2 DLX5 ZMIZ1 NFE4 SMAD1 CRTC2 TET1 SMAD5 ZMYND8 | 1.16e-06 | 1390 | 46 | 14 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | GLIS3 BMI1 HOXB4 MYOCD CTBP2 SIN3A DRAP1 TENM2 TET1 SMAD5 ZMYND8 | 1.49e-05 | 1053 | 46 | 11 | GO:0000122 |
| GeneOntologyBiologicalProcess | developmental growth | 2.57e-05 | 911 | 46 | 10 | GO:0048589 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 3.25e-05 | 276 | 46 | 6 | GO:0007179 | |
| GeneOntologyBiologicalProcess | embryo development | BMI1 HOXB4 CELSR1 DLX5 SIN3A ZMIZ1 STIL SOBP CECR2 SMAD1 TET1 SMAD5 | 5.26e-05 | 1437 | 46 | 12 | GO:0009790 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 5.37e-05 | 445 | 46 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | growth | PTCH2 AUTS2 MYOCD SIN3A ZMIZ1 SIK3 STIL MBD5 ATXN2 SMAD1 RAI1 | 6.49e-05 | 1235 | 46 | 11 | GO:0040007 |
| GeneOntologyBiologicalProcess | osteoblast fate commitment | 7.26e-05 | 6 | 46 | 2 | GO:0002051 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 8.86e-05 | 482 | 46 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 9.67e-05 | 336 | 46 | 6 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.08e-04 | 343 | 46 | 6 | GO:0071559 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 1.23e-04 | 351 | 46 | 6 | GO:0048562 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.60e-04 | 713 | 46 | 8 | GO:0048598 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | GLIS3 BMI1 HOXB4 MYOCD CTBP2 SIN3A DRAP1 TENM2 TET1 SMAD5 ZMYND8 | 1.97e-04 | 1399 | 46 | 11 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | GLIS3 BMI1 HOXB4 MYOCD CTBP2 SIN3A DRAP1 TENM2 TET1 SMAD5 ZMYND8 | 2.15e-04 | 1413 | 46 | 11 | GO:1902679 |
| GeneOntologyBiologicalProcess | multicellular organism growth | 2.25e-04 | 249 | 46 | 5 | GO:0035264 | |
| GeneOntologyBiologicalProcess | central nervous system development | 2.50e-04 | 1197 | 46 | 10 | GO:0007417 | |
| GeneOntologyBiologicalProcess | bone development | 2.95e-04 | 264 | 46 | 5 | GO:0060348 | |
| GeneOntologyBiologicalProcess | skeletal system development | 3.94e-04 | 615 | 46 | 7 | GO:0001501 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 5.22e-04 | 850 | 46 | 8 | GO:0071363 | |
| GeneOntologyBiologicalProcess | brain development | 5.60e-04 | 859 | 46 | 8 | GO:0007420 | |
| GeneOntologyBiologicalProcess | somatic stem cell division | 6.48e-04 | 17 | 46 | 2 | GO:0048103 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organism growth | 6.48e-04 | 17 | 46 | 2 | GO:0040015 | |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 6.48e-04 | 17 | 46 | 2 | GO:0016081 | |
| GeneOntologyBiologicalProcess | response to growth factor | 6.71e-04 | 883 | 46 | 8 | GO:0070848 | |
| GeneOntologyBiologicalProcess | negative regulation of receptor internalization | 7.28e-04 | 18 | 46 | 2 | GO:0002091 | |
| GeneOntologyBiologicalProcess | chromatin organization | 7.39e-04 | 896 | 46 | 8 | GO:0006325 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 7.94e-04 | 906 | 46 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | head development | 8.71e-04 | 919 | 46 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | anatomical structure regression | 9.01e-04 | 20 | 46 | 2 | GO:0060033 | |
| GeneOntologyBiologicalProcess | positive regulation of fibroblast proliferation | 9.02e-04 | 85 | 46 | 3 | GO:0048146 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | 9.06e-04 | 338 | 46 | 5 | GO:0042593 | |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | 9.18e-04 | 339 | 46 | 5 | GO:0033500 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 9.35e-04 | 929 | 46 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | positive regulation of osteoblast differentiation | 9.98e-04 | 88 | 46 | 3 | GO:0045669 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.05e-03 | 526 | 46 | 6 | GO:0007389 | |
| GeneOntologyBiologicalProcess | neural tube development | 1.06e-03 | 202 | 46 | 4 | GO:0021915 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 1.07e-03 | 1186 | 46 | 9 | GO:0007167 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 1.10e-03 | 91 | 46 | 3 | GO:0009880 | |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 1.17e-03 | 93 | 46 | 3 | GO:0040014 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 1.19e-03 | 741 | 46 | 7 | GO:0006338 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.47e-03 | 561 | 46 | 6 | GO:0048568 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 1.49e-03 | 999 | 46 | 8 | GO:0071824 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell population maintenance | 1.53e-03 | 26 | 46 | 2 | GO:1902455 | |
| GeneOntologyCellularComponent | chromatin | TFDP3 BMI1 HOXB4 MYOCD POU6F2 DLX5 SIN3A ZMIZ1 BAZ2B CECR2 SMAD1 TET1 SMAD5 ZMYND8 | 2.08e-06 | 1480 | 46 | 14 | GO:0000785 |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 1.32e-04 | 8 | 46 | 2 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 2.11e-04 | 10 | 46 | 2 | GO:0071141 | |
| GeneOntologyCellularComponent | transcription regulator complex | 3.01e-04 | 596 | 46 | 7 | GO:0005667 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 3.19e-04 | 272 | 46 | 5 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 6.83e-04 | 1377 | 46 | 10 | GO:0140513 | |
| GeneOntologyCellularComponent | transcription repressor complex | 9.29e-04 | 87 | 46 | 3 | GO:0017053 | |
| GeneOntologyCellularComponent | Sin3-type complex | 1.06e-03 | 22 | 46 | 2 | GO:0070822 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.16e-03 | 23 | 46 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | ribbon synapse | 2.25e-03 | 32 | 46 | 2 | GO:0097470 | |
| GeneOntologyCellularComponent | cell cortex region | 4.42e-03 | 45 | 46 | 2 | GO:0099738 | |
| MousePheno | delayed neural tube closure | 1.71e-06 | 31 | 40 | 4 | MP:0002621 | |
| MousePheno | abnormal ventral body wall morphology | 2.79e-05 | 21 | 40 | 3 | MP:0003384 | |
| MousePheno | abnormal neural tube morphology | 3.43e-05 | 591 | 40 | 9 | MP:0002151 | |
| MousePheno | abnormal embryonic tissue morphology | AUTS2 CTBP2 CELSR1 DLX5 LASP1 ZMIZ1 STIL DRAP1 CECR2 SMAD1 TET1 SMAD5 | 4.31e-05 | 1116 | 40 | 12 | MP:0002085 |
| MousePheno | abnormal bile duct physiology | 4.78e-05 | 25 | 40 | 3 | MP:0003252 | |
| MousePheno | intrahepatic cholestasis | 7.94e-05 | 5 | 40 | 2 | MP:0005415 | |
| MousePheno | abnormal neural tube closure | 8.63e-05 | 378 | 40 | 7 | MP:0003720 | |
| MousePheno | abnormal cartilaginous joint morphology | 9.85e-05 | 85 | 40 | 4 | MP:0030875 | |
| Domain | Bromodomain | 1.04e-04 | 38 | 45 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.31e-04 | 41 | 45 | 3 | PS50014 | |
| Domain | BROMO | 1.40e-04 | 42 | 45 | 3 | SM00297 | |
| Domain | Bromodomain | 1.40e-04 | 42 | 45 | 3 | IPR001487 | |
| Domain | - | 1.40e-04 | 42 | 45 | 3 | 1.20.920.10 | |
| Domain | Dwarfin | 1.57e-04 | 8 | 45 | 2 | IPR013790 | |
| Domain | DWB | 1.57e-04 | 8 | 45 | 2 | SM00524 | |
| Domain | MH2 | 1.57e-04 | 8 | 45 | 2 | PS51076 | |
| Domain | MH1 | 1.57e-04 | 8 | 45 | 2 | PS51075 | |
| Domain | - | 1.57e-04 | 8 | 45 | 2 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 1.57e-04 | 8 | 45 | 2 | IPR013019 | |
| Domain | MH2 | 1.57e-04 | 8 | 45 | 2 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 1.57e-04 | 8 | 45 | 2 | IPR001132 | |
| Domain | Methyl_CpG_DNA-bd | 3.08e-04 | 11 | 45 | 2 | IPR001739 | |
| Domain | MBD | 3.08e-04 | 11 | 45 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 3.08e-04 | 11 | 45 | 2 | IPR016177 | |
| Domain | MBD | 3.08e-04 | 11 | 45 | 2 | SM00391 | |
| Domain | MBD | 3.08e-04 | 11 | 45 | 2 | PS50982 | |
| Domain | MAD_homology1_Dwarfin-type | 3.69e-04 | 12 | 45 | 2 | IPR003619 | |
| Domain | DWA | 3.69e-04 | 12 | 45 | 2 | SM00523 | |
| Domain | MH1 | 3.69e-04 | 12 | 45 | 2 | PF03165 | |
| Domain | SMAD_dom-like | 6.67e-04 | 16 | 45 | 2 | IPR017855 | |
| Domain | - | 6.67e-04 | 16 | 45 | 2 | 2.60.200.10 | |
| Domain | PHD | 1.28e-03 | 89 | 45 | 3 | SM00249 | |
| Domain | Znf_PHD | 1.37e-03 | 91 | 45 | 3 | IPR001965 | |
| Domain | PWWP | 1.39e-03 | 23 | 45 | 2 | PF00855 | |
| Domain | PWWP_dom | 1.39e-03 | 23 | 45 | 2 | IPR000313 | |
| Domain | PWWP | 1.51e-03 | 24 | 45 | 2 | PS50812 | |
| Domain | ZF_PHD_2 | 1.55e-03 | 95 | 45 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.60e-03 | 96 | 45 | 3 | PS01359 | |
| Domain | Bromodomain_CS | 1.78e-03 | 26 | 45 | 2 | IPR018359 | |
| Domain | EGF_CA | 3.16e-03 | 122 | 45 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.31e-03 | 124 | 45 | 3 | IPR001881 | |
| Domain | BROMODOMAIN_1 | 3.58e-03 | 37 | 45 | 2 | PS00633 | |
| Domain | SMAD_FHA_domain | 6.97e-03 | 52 | 45 | 2 | IPR008984 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY | 1.40e-04 | 7 | 37 | 2 | M47845 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY | 1.86e-04 | 8 | 37 | 2 | M47847 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 2.34e-04 | 46 | 37 | 3 | MM15949 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY | 2.39e-04 | 9 | 37 | 2 | M47844 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY | 2.39e-04 | 9 | 37 | 2 | M47822 | |
| Pathway | REACTOME_HEME_SIGNALING | 2.82e-04 | 49 | 37 | 3 | M41832 | |
| Pathway | PID_ALK2_PATHWAY | 3.63e-04 | 11 | 37 | 2 | M203 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY | 3.63e-04 | 11 | 37 | 2 | M47848 | |
| Pathway | WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION | 5.13e-04 | 13 | 37 | 2 | M39378 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP47 | 7.86e-04 | 16 | 37 | 2 | M39675 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 8.07e-04 | 70 | 37 | 3 | M938 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 9.12e-04 | 73 | 37 | 3 | M39401 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 9.99e-04 | 18 | 37 | 2 | MM15034 | |
| Pathway | WP_BMP_SIGNALING_PATHWAY_IN_EYELID_DEVELOPMENT | 1.24e-03 | 20 | 37 | 2 | MM15907 | |
| Pathway | WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT | 1.24e-03 | 20 | 37 | 2 | M39624 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY | 1.24e-03 | 20 | 37 | 2 | M47843 | |
| Pathway | PID_HEDGEHOG_2PATHWAY | 1.50e-03 | 22 | 37 | 2 | M211 | |
| Pathway | WP_HEDGEHOG_SIGNALING_PATHWAY | 1.50e-03 | 22 | 37 | 2 | MM15924 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 1.78e-03 | 24 | 37 | 2 | M11420 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 1.78e-03 | 24 | 37 | 2 | MM1373 | |
| Pathway | WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE | 1.94e-03 | 25 | 37 | 2 | M39665 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 1.94e-03 | 25 | 37 | 2 | MM15546 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 2.07e-03 | 97 | 37 | 3 | MM15926 | |
| Pathway | PID_ALK1_PATHWAY | 2.09e-03 | 26 | 37 | 2 | M185 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 2.09e-03 | 26 | 37 | 2 | M47923 | |
| Pathway | REACTOME_CARDIOGENESIS | 2.26e-03 | 27 | 37 | 2 | M48011 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 2.32e-03 | 101 | 37 | 3 | M39448 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 2.97e-03 | 31 | 37 | 2 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 2.97e-03 | 31 | 37 | 2 | MM14789 | |
| Pubmed | Mapping mouse hemangioblast maturation from headfold stages. | 8.06e-08 | 7 | 47 | 3 | 22426104 | |
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 20843790 | ||
| Pubmed | 1.29e-07 | 8 | 47 | 3 | 28574994 | ||
| Pubmed | 1.29e-07 | 8 | 47 | 3 | 12714599 | ||
| Pubmed | 1.93e-07 | 9 | 47 | 3 | 30770380 | ||
| Pubmed | 1.93e-07 | 9 | 47 | 3 | 19934017 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 2.20e-07 | 877 | 47 | 10 | 20211142 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | AUTS2 TJAP1 CHD9 CFAP20DC CTBP2 POU6F2 ZMIZ1 SMG7 MBD5 ATXN2 SOBP RAI1 | 4.71e-07 | 1489 | 47 | 12 | 28611215 |
| Pubmed | Excess NF-κB induces ectopic odontogenesis in embryonic incisor epithelium. | 6.55e-07 | 13 | 47 | 3 | 25376721 | |
| Pubmed | 6.55e-07 | 13 | 47 | 3 | 26989192 | ||
| Pubmed | 8.33e-07 | 14 | 47 | 3 | 17693062 | ||
| Pubmed | 1.04e-06 | 15 | 47 | 3 | 22547067 | ||
| Pubmed | 1.04e-06 | 15 | 47 | 3 | 23863482 | ||
| Pubmed | Teashirt 3 is necessary for ureteral smooth muscle differentiation downstream of SHH and BMP4. | 1.55e-06 | 17 | 47 | 3 | 18776146 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.73e-06 | 430 | 47 | 7 | 35044719 | |
| Pubmed | Sin3A recruits Tet1 to the PAH1 domain via a highly conserved Sin3-Interaction Domain. | 1.79e-06 | 2 | 47 | 2 | 30279502 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 18446813 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21723296 | ||
| Pubmed | Regulation of the levels of Smad1 and Smad5 in MC3T3-E1 cells by Icariine in vitro. | 1.79e-06 | 2 | 47 | 2 | 24297369 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 26711875 | ||
| Pubmed | The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling. | 1.79e-06 | 2 | 47 | 2 | 11451566 | |
| Pubmed | BMP-SMAD1/5 Signaling Regulates Retinal Vascular Development. | 1.79e-06 | 2 | 47 | 2 | 32210087 | |
| Pubmed | Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma. | 1.79e-06 | 2 | 47 | 2 | 31686349 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 23387849 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 25853262 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 29733394 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 8799132 | ||
| Pubmed | 1.86e-06 | 18 | 47 | 3 | 27335460 | ||
| Pubmed | 2.31e-06 | 157 | 47 | 5 | 30186101 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.58e-06 | 457 | 47 | 7 | 32344865 | |
| Pubmed | Myocardin regulates BMP10 expression and is required for heart development. | 2.59e-06 | 20 | 47 | 3 | 22996691 | |
| Pubmed | 2.59e-06 | 20 | 47 | 3 | 28655168 | ||
| Pubmed | Roles of organizer factors and BMP antagonism in mammalian forebrain establishment. | 2.59e-06 | 20 | 47 | 3 | 16839541 | |
| Pubmed | Myocardial smad4 is essential for cardiogenesis in mouse embryos. | 3.50e-06 | 22 | 47 | 3 | 17585069 | |
| Pubmed | 3.50e-06 | 22 | 47 | 3 | 36314682 | ||
| Pubmed | Hedgehog signaling patterns the oral-aboral axis of the mandibular arch. | 3.50e-06 | 22 | 47 | 3 | 30638444 | |
| Pubmed | Neural crest cells require Meis2 for patterning the mandibular arch via the Sonic hedgehog pathway. | 4.02e-06 | 23 | 47 | 3 | 32616504 | |
| Pubmed | Msx genes define a population of mural cell precursors required for head blood vessel maturation. | 4.02e-06 | 23 | 47 | 3 | 21693521 | |
| Pubmed | 4.59e-06 | 24 | 47 | 3 | 29852132 | ||
| Pubmed | 5.21e-06 | 25 | 47 | 3 | 20019329 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 10652350 | ||
| Pubmed | Non-canonical cyclic AMP SMAD1/5/8 signalling in human granulosa cells. | 5.36e-06 | 3 | 47 | 2 | 30953749 | |
| Pubmed | Regulation of BMP4/Dpp retrotranslocation and signaling by deglycosylation. | 5.36e-06 | 3 | 47 | 2 | 32720893 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 29376829 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 21381028 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 20371744 | ||
| Pubmed | BMP signaling initiates a neural crest differentiation program in embryonic rat CNS stem cells. | 5.36e-06 | 3 | 47 | 2 | 15246821 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 22964636 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 25505291 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 23918166 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 24023003 | ||
| Pubmed | Complementary and independent function for Hoxb4 and Bmi1 in HSC activity. | 5.36e-06 | 3 | 47 | 2 | 19022763 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 27848974 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 20522807 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 31127639 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 22897816 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 19096363 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 33463047 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 21945631 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 14711801 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 22670624 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 30367512 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 25165122 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 12649288 | ||
| Pubmed | [Clinical significance of leukemia stem/progenitor cell related gene expression in acute leukemia]. | 5.36e-06 | 3 | 47 | 2 | 22040961 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 25880873 | ||
| Pubmed | Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. | 5.36e-06 | 3 | 47 | 2 | 16247476 | |
| Pubmed | 6.72e-06 | 529 | 47 | 7 | 14621295 | ||
| Pubmed | 7.40e-06 | 28 | 47 | 3 | 20881014 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 7.67e-06 | 351 | 47 | 6 | 38297188 | |
| Pubmed | Spatiotemporal regulation of GLI target genes in the mammalian limb bud. | 8.91e-06 | 207 | 47 | 5 | 26238476 | |
| Pubmed | Loss of Neogenin alters branchial arch development and leads to craniofacial skeletal defects. | 9.15e-06 | 30 | 47 | 3 | 38404688 | |
| Pubmed | Msx1 is essential for proper rostral tip formation of the mouse mandible. | 1.07e-05 | 4 | 47 | 2 | 36566565 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 19247629 | ||
| Pubmed | A crucial role of a high mobility group protein HMGA2 in cardiogenesis. | 1.07e-05 | 4 | 47 | 2 | 18425117 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 23993924 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 17676934 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 27335065 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 15557274 | ||
| Pubmed | The transcriptional co-regulator Jab1 is crucial for chondrocyte differentiation in vivo. | 1.07e-05 | 4 | 47 | 2 | 23203803 | |
| Pubmed | Suv39h histone methyltransferases interact with Smads and cooperate in BMP-induced repression. | 1.07e-05 | 4 | 47 | 2 | 15107829 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 17967875 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 32374006 | ||
| Pubmed | Endothelial Msx1 transduces hemodynamic changes into an arteriogenic remodeling response. | 1.07e-05 | 4 | 47 | 2 | 26391659 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 22452883 | ||
| Pubmed | TGFβ signaling promotes juvenile granulosa cell tumorigenesis by suppressing apoptosis. | 1.07e-05 | 4 | 47 | 2 | 25243859 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 21239498 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 25536014 | ||
| Pubmed | Characterization of new bone morphogenetic protein (Bmp)-2 regulatory alleles. | 1.07e-05 | 4 | 47 | 2 | 28401685 | |
| Pubmed | SMAD1/5 signaling in osteoclasts regulates bone formation via coupling factors. | 1.07e-05 | 4 | 47 | 2 | 30188920 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 18684712 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 19244313 | ||
| Pubmed | Signal transduction of bone morphogenetic protein receptors. | 1.07e-05 | 4 | 47 | 2 | 14687659 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 17359969 | ||
| Pubmed | Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice. | 1.07e-05 | 4 | 47 | 2 | 28438754 | |
| Pubmed | Interaction of TGFβ and BMP signaling pathways during chondrogenesis. | 1.07e-05 | 4 | 47 | 2 | 21297990 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 24021264 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 25755279 | ||
| Pubmed | The SMAD Pathway Is Required for Hepcidin Response During Endoplasmic Reticulum Stress. | 1.07e-05 | 4 | 47 | 2 | 27483343 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 34719843 | ||
| Interaction | GDF6 interactions | 4.13e-07 | 7 | 47 | 3 | int:GDF6 | |
| Interaction | FXR2 interactions | 5.60e-07 | 430 | 47 | 9 | int:FXR2 | |
| Interaction | TLE3 interactions | 2.27e-06 | 376 | 47 | 8 | int:TLE3 | |
| Interaction | NKX3-2 interactions | 3.34e-06 | 13 | 47 | 3 | int:NKX3-2 | |
| Interaction | TRIP6 interactions | 1.80e-05 | 358 | 47 | 7 | int:TRIP6 | |
| Interaction | YTHDF3 interactions | 2.20e-05 | 246 | 47 | 6 | int:YTHDF3 | |
| Interaction | GUSBP5 interactions | 2.80e-05 | 75 | 47 | 4 | int:GUSBP5 | |
| Interaction | NUP35 interactions | 5.28e-05 | 424 | 47 | 7 | int:NUP35 | |
| Interaction | DZIP3 interactions | 6.58e-05 | 183 | 47 | 5 | int:DZIP3 | |
| Interaction | STUB1 interactions | 7.29e-05 | 608 | 47 | 8 | int:STUB1 | |
| Interaction | SMAD3 interactions | 7.36e-05 | 447 | 47 | 7 | int:SMAD3 | |
| Interaction | YTHDF2 interactions | 8.26e-05 | 312 | 47 | 6 | int:YTHDF2 | |
| Interaction | TGIF1 interactions | 1.19e-04 | 41 | 47 | 3 | int:TGIF1 | |
| Interaction | TET1 interactions | 1.57e-04 | 45 | 47 | 3 | int:TET1 | |
| Interaction | KLF10 interactions | 1.57e-04 | 45 | 47 | 3 | int:KLF10 | |
| Interaction | OAZ3 interactions | 1.57e-04 | 45 | 47 | 3 | int:OAZ3 | |
| Interaction | H2BC21 interactions | 1.86e-04 | 696 | 47 | 8 | int:H2BC21 | |
| Interaction | MARF1 interactions | 2.24e-04 | 128 | 47 | 4 | int:MARF1 | |
| Interaction | MKRN2 interactions | 2.59e-04 | 385 | 47 | 6 | int:MKRN2 | |
| Interaction | MXI1 interactions | 2.86e-04 | 55 | 47 | 3 | int:MXI1 | |
| Interaction | SMAD6 interactions | 3.02e-04 | 56 | 47 | 3 | int:SMAD6 | |
| Interaction | HELZ interactions | 3.21e-04 | 257 | 47 | 5 | int:HELZ | |
| Interaction | XRN1 interactions | 3.27e-04 | 258 | 47 | 5 | int:XRN1 | |
| Interaction | SPATA12 interactions | 3.46e-04 | 12 | 47 | 2 | int:SPATA12 | |
| Interaction | PRRC2B interactions | 3.70e-04 | 265 | 47 | 5 | int:PRRC2B | |
| Interaction | TCF20 interactions | 3.70e-04 | 146 | 47 | 4 | int:TCF20 | |
| GeneFamily | SMAD family | 5.54e-05 | 8 | 26 | 2 | 750 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.09e-04 | 11 | 26 | 2 | 1025 | |
| GeneFamily | PWWP domain containing | 4.51e-04 | 22 | 26 | 2 | 1147 | |
| GeneFamily | PHD finger proteins | 7.37e-03 | 90 | 26 | 2 | 88 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 5.73e-08 | 300 | 47 | 8 | M8702 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | FRS3 AUTS2 CACNA1E SIN3A ZMIZ1 SIK3 TENM2 SOBP RAI1 CPEB4 ZMYND8 | 3.09e-06 | 1106 | 47 | 11 | M39071 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 6.15e-06 | 145 | 47 | 5 | M1810 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.81e-05 | 856 | 47 | 9 | M4500 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.83e-05 | 466 | 47 | 7 | M13522 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 2.71e-05 | 197 | 47 | 5 | M4421 | |
| Coexpression | HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN | 3.39e-05 | 102 | 47 | 4 | M2124 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | 1.15e-04 | 843 | 47 | 8 | M2356 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 1.20e-04 | 141 | 47 | 4 | M39235 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | GLIS3 AUTS2 HOXB4 MYOCD CELSR1 ZMIZ1 TENM2 CECR2 SMAD5 CPEB4 | 7.53e-06 | 795 | 47 | 10 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 8.04e-06 | 801 | 47 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.19e-05 | 259 | 47 | 6 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | 1.01e-04 | 495 | 47 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500_K0 | 1.68e-04 | 926 | 47 | 9 | facebase_RNAseq_e10.5_OlfacPit_2500_K0 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | GLIS3 NAV2 CFAP20DC CELSR1 SIN3A LASP1 ZMIZ1 CHERP CECR2 RAI1 | 2.23e-04 | 1187 | 47 | 10 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.48e-04 | 256 | 47 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.61e-04 | 406 | 47 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 2.64e-04 | 984 | 47 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.74e-04 | 142 | 47 | 4 | gudmap_developingKidney_e15.5_1000_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 2.74e-04 | 142 | 47 | 4 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | 2.80e-04 | 779 | 47 | 8 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#3 | 2.88e-04 | 144 | 47 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 3.08e-04 | 790 | 47 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#1_top-relative-expression-ranked_100 | 3.12e-04 | 12 | 47 | 2 | gudmap_developingKidney_e12.5_renal vesicle_100_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 3.52e-04 | 806 | 47 | 8 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.81e-04 | 281 | 47 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.00e-04 | 284 | 47 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.07e-04 | 285 | 47 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K3 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#3 | 4.22e-04 | 66 | 47 | 3 | ratio_DE_vs_SC_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 4.51e-04 | 162 | 47 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 4.75e-04 | 843 | 47 | 8 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 4.78e-04 | 844 | 47 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_k-means-cluster#1_top-relative-expression-ranked_200 | 5.64e-04 | 16 | 47 | 2 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_k1_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_500 | 5.90e-04 | 74 | 47 | 3 | gudmap_developingKidney_e15.5_S-shaped body_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.67e-04 | 498 | 47 | 6 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.22e-08 | 198 | 47 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-06 | 197 | 47 | 5 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-06 | 197 | 47 | 5 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-06 | 197 | 47 | 5 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.24e-05 | 172 | 47 | 4 | e3a8891694343b6b01e80a200ae338d24797e417 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 3.39e-05 | 174 | 47 | 4 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 3.46e-05 | 175 | 47 | 4 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 3.86e-05 | 180 | 47 | 4 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 185 | 47 | 4 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 4.30e-05 | 185 | 47 | 4 | 520795866d44def5be3910ce8e728045c716a24d | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 4.30e-05 | 185 | 47 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 185 | 47 | 4 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-05 | 186 | 47 | 4 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-05 | 188 | 47 | 4 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.58e-05 | 188 | 47 | 4 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.67e-05 | 189 | 47 | 4 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-05 | 190 | 47 | 4 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.77e-05 | 190 | 47 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.77e-05 | 190 | 47 | 4 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.77e-05 | 190 | 47 | 4 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.77e-05 | 190 | 47 | 4 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.87e-05 | 191 | 47 | 4 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.87e-05 | 191 | 47 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 4.87e-05 | 191 | 47 | 4 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 4.97e-05 | 192 | 47 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 4.97e-05 | 192 | 47 | 4 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.07e-05 | 193 | 47 | 4 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 5.07e-05 | 193 | 47 | 4 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.07e-05 | 193 | 47 | 4 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 5.17e-05 | 194 | 47 | 4 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | Mild-NK|Mild / Disease group and Cell class | 5.27e-05 | 195 | 47 | 4 | be88a7507cd6a0a9dfe424312d9365039eef7b74 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 5.27e-05 | 195 | 47 | 4 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.27e-05 | 195 | 47 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 196 | 47 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 5.49e-05 | 197 | 47 | 4 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.60e-05 | 198 | 47 | 4 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 5.82e-05 | 200 | 47 | 4 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.42e-04 | 141 | 47 | 3 | a32947b13e888850c979a54c137512e4b96d2f36 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.42e-04 | 141 | 47 | 3 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.42e-04 | 141 | 47 | 3 | 2cb651d63466fdcce011d1dd8de409ef439d03e7 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.51e-04 | 142 | 47 | 3 | c3a5a80f78704d34db5df85d6e3e8fc84ff24268 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-04 | 146 | 47 | 3 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.50e-04 | 152 | 47 | 3 | 854c841c1fc6300b7e9be9c98cbf9b0ce2678690 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.71e-04 | 154 | 47 | 3 | 020697ae8463b18f9b4270c404f52ce4c0e90135 | |
| ToppCell | Mild_COVID-19-Myeloid-TRAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.71e-04 | 154 | 47 | 3 | ab648f6b29eb9e499e46cbdbaf3c5cf6b94d1f64 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-04 | 157 | 47 | 3 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | Hippocampus-Endothelial-MURAL|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.15e-04 | 158 | 47 | 3 | 2d73b5e59c650c603fec6223b1c51f0962f7bc81 | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.15e-04 | 158 | 47 | 3 | 7f4a644534b78f7e7539cae1fd895dad6f96862b | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-3|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 6.50e-04 | 161 | 47 | 3 | 52239a887799362256ecd7e740b716b88ed59a62 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.61e-04 | 162 | 47 | 3 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.85e-04 | 164 | 47 | 3 | d6f71d804bb65301c02ea4e6673e20688b5fcd5b | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.10e-04 | 166 | 47 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-04 | 167 | 47 | 3 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.35e-04 | 168 | 47 | 3 | 27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.35e-04 | 168 | 47 | 3 | 240ea32b64d86f9216785010d6b237d9adf052c9 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | ca65321259711321c175ede67bd67a47aad81d7a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.35e-04 | 168 | 47 | 3 | b4bb03efb601a61465260f93896c56861c588bef | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.48e-04 | 169 | 47 | 3 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 7.48e-04 | 169 | 47 | 3 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.48e-04 | 169 | 47 | 3 | a34aff9257ae9746226ee7af595c4678a4b0c896 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.48e-04 | 169 | 47 | 3 | e7470a5b060881b2a8ce2ab04b0788396aa13889 | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 7.61e-04 | 170 | 47 | 3 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 7.61e-04 | 170 | 47 | 3 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 8.00e-04 | 173 | 47 | 3 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 8.00e-04 | 173 | 47 | 3 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 173 | 47 | 3 | a37f38478473290fe35aea8684befc3bf95b161f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 173 | 47 | 3 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 173 | 47 | 3 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.13e-04 | 174 | 47 | 3 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.27e-04 | 175 | 47 | 3 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 8.27e-04 | 175 | 47 | 3 | b30589ff9dc18e745afe61f289e6d576c9c6c6b2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.41e-04 | 176 | 47 | 3 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.55e-04 | 177 | 47 | 3 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.55e-04 | 177 | 47 | 3 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.55e-04 | 177 | 47 | 3 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.69e-04 | 178 | 47 | 3 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.69e-04 | 178 | 47 | 3 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.69e-04 | 178 | 47 | 3 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-04 | 178 | 47 | 3 | 7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.69e-04 | 178 | 47 | 3 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.83e-04 | 179 | 47 | 3 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.83e-04 | 179 | 47 | 3 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 8.83e-04 | 179 | 47 | 3 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-04 | 179 | 47 | 3 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.83e-04 | 179 | 47 | 3 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 8.83e-04 | 179 | 47 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.97e-04 | 180 | 47 | 3 | 455d1e3ccf2ab609954f3b870e8f514ddca735f4 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.97e-04 | 180 | 47 | 3 | d33bb00f2b7d07dda9015cb8eafd742c2b2e9ace | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.97e-04 | 180 | 47 | 3 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.12e-04 | 181 | 47 | 3 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 9.12e-04 | 181 | 47 | 3 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-04 | 182 | 47 | 3 | be9c312a44868d4ee266a64d066feb8c5bce5687 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.26e-04 | 182 | 47 | 3 | da61e7cb2537c567968d8bd8baf537ecdff0ab18 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-04 | 182 | 47 | 3 | 22d6f4790950508e8aa27e02a8133af5f53f13c8 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.26e-04 | 182 | 47 | 3 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-04 | 182 | 47 | 3 | 74dbb706bcaa0f8c922bf3b0424bce5bb27167fa | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 9.26e-04 | 182 | 47 | 3 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Cerebellum-Endothelial-MURAL|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.26e-04 | 182 | 47 | 3 | b2f03f61aebb5920595fed8b9d6799a09353419b | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.41e-04 | 183 | 47 | 3 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| Disease | cortical surface area measurement | GLIS3 NAV2 AUTS2 CTBP2 RIN3 CELSR1 ATXN2 BAZ2B TENM2 SMAD5 CPEB4 MAP3K14 | 7.06e-07 | 1345 | 46 | 12 | EFO_0010736 |
| Disease | cortical thickness | GLIS3 NAV2 AUTS2 CTBP2 RIN3 CELSR1 DLX5 SMG7 ATXN2 TENM2 CPEB4 | 8.30e-07 | 1113 | 46 | 11 | EFO_0004840 |
| Disease | neuroticism measurement, cognitive function measurement | 2.40e-06 | 566 | 46 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | mean platelet volume | 3.06e-06 | 1020 | 46 | 10 | EFO_0004584 | |
| Disease | autosomal dominant intellectual developmental disorder (implicated_via_orthology) | 7.13e-06 | 3 | 46 | 2 | DOID:0060307 (implicated_via_orthology) | |
| Disease | wellbeing measurement | 1.04e-05 | 692 | 46 | 8 | EFO_0007869 | |
| Disease | eosinophil count | RIN3 CELSR1 SIK3 CHERP MBD5 ATXN2 GGCX RAI1 CPEB4 MAP3K14 ZMYND8 | 1.35e-05 | 1488 | 46 | 11 | EFO_0004842 |
| Disease | urate measurement | 6.52e-05 | 895 | 46 | 8 | EFO_0004531 | |
| Disease | AUTISM, SUSCEPTIBILITY TO, 15 | 6.62e-05 | 8 | 46 | 2 | C2677504 | |
| Disease | reaction time measurement | 6.68e-05 | 658 | 46 | 7 | EFO_0008393 | |
| Disease | feeling emotionally hurt measurement | 9.28e-05 | 56 | 46 | 3 | EFO_0009599 | |
| Disease | anthropometric measurement | 1.37e-04 | 168 | 46 | 4 | EFO_0004302 | |
| Disease | monocyte count | 1.72e-04 | 1320 | 46 | 9 | EFO_0005091 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.83e-04 | 13 | 46 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | smoking behavior | 1.86e-04 | 341 | 46 | 5 | EFO_0004318 | |
| Disease | grip strength measurement | 2.10e-04 | 350 | 46 | 5 | EFO_0006941 | |
| Disease | neuroimaging measurement | 2.22e-04 | 1069 | 46 | 8 | EFO_0004346 | |
| Disease | atrial fibrillation | 2.75e-04 | 371 | 46 | 5 | EFO_0000275 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 2.81e-04 | 16 | 46 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 3.20e-04 | 85 | 46 | 3 | C1510586 | |
| Disease | biological sex | 4.54e-04 | 230 | 46 | 4 | PATO_0000047 | |
| Disease | neuroticism measurement | 4.83e-04 | 909 | 46 | 7 | EFO_0007660 | |
| Disease | depressive symptom measurement | 5.16e-04 | 426 | 46 | 5 | EFO_0007006 | |
| Disease | physical activity measurement | 5.76e-04 | 245 | 46 | 4 | EFO_0008002 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 6.41e-04 | 447 | 46 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | response to peginterferon alfa-2a | 6.97e-04 | 25 | 46 | 2 | EFO_0010103 | |
| Disease | breast cancer, lung cancer | 6.97e-04 | 25 | 46 | 2 | MONDO_0007254, MONDO_0008903 | |
| Disease | testosterone measurement | 7.17e-04 | 1275 | 46 | 8 | EFO_0004908 | |
| Disease | monocyte percentage of leukocytes | 9.12e-04 | 731 | 46 | 6 | EFO_0007989 | |
| Disease | celiac disease | 1.01e-03 | 126 | 46 | 3 | EFO_0001060 | |
| Disease | eosinophil percentage of leukocytes | 1.01e-03 | 746 | 46 | 6 | EFO_0007991 | |
| Disease | microcephaly (implicated_via_orthology) | 1.14e-03 | 32 | 46 | 2 | DOID:10907 (implicated_via_orthology) | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.41e-03 | 312 | 46 | 4 | EFO_0004612, EFO_0010351 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.46e-03 | 315 | 46 | 4 | EFO_0004574, EFO_0004612 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AHPSQAPSPNQPTKH | 421 | P56545 | |
| SNSPHPQQSQHASPQ | 2211 | Q15878 | |
| SSPAHPKQTLENNHP | 466 | Q9UIF8 | |
| LSVSHSAQPPAHQPP | 501 | Q9HCU0 | |
| NPAPTPDFPFQIHNS | 621 | Q9NYQ6 | |
| HPHAHPPTSNQSPAS | 236 | P56178 | |
| PASHPQHFPPRGFQS | 1171 | Q9BXF3 | |
| KDHPHPFLSQSNPPT | 136 | Q86UQ8 | |
| SQPPPQASHPSAHFQ | 156 | Q14919 | |
| QASHPSAHFQSPPTP | 161 | Q14919 | |
| LPFPQGTHFPQHSQS | 201 | Q7Z5J4 | |
| IPHNFGHSQPPPINS | 261 | Q9Y6F1 | |
| QQQSQHGGSHPAPSP | 1156 | Q99700 | |
| PHHIPTSAPVYQQPQ | 161 | Q14847 | |
| STPVQSPHPQFPHIS | 276 | P35226 | |
| PNHSPLHSFTPTLQP | 436 | Q8WXX7 | |
| PQHISLPPSPNNPHF | 646 | Q8IZQ8 | |
| PCAQNPLHPSPSHSA | 121 | P17483 | |
| PHSQFNCSPIHPQNQ | 96 | Q3L8U1 | |
| QHPQFNQPPHPHNFN | 531 | Q8IWX8 | |
| LSSPQPQLQGSHSHP | 356 | Q53ET0 | |
| PPHHNNNNEAPSECP | 266 | O43559 | |
| HNVQGSPHNPSSQLP | 586 | Q8NEA6 | |
| SPVNNHHSPGQTPTL | 231 | Q96L14 | |
| PSNSTSNNHLPHPLN | 901 | Q9P267 | |
| PHPPPFTHRNAAFNQ | 256 | Q17RY0 | |
| KFPSPPHSSNGHSPQ | 21 | Q9ULU4 | |
| QHPPAQATAHSQSSP | 511 | Q8TB24 | |
| EPRHPPPNQANYHQT | 671 | Q99558 | |
| TPDQHQASQTHPPFP | 76 | P78424 | |
| PPSAPNHHSRQAPNV | 261 | Q9Y6C5 | |
| SLPSSPPTHNHNSVP | 1011 | Q92540 | |
| PPTHNHNSVPFSNFG | 1016 | Q92540 | |
| PCQPHQPAPHQQSKA | 236 | Q8IVL1 | |
| HPSQPSAQSAPAPAQ | 226 | Q96ST3 | |
| HPNNHLFRQPSNSPP | 736 | Q9Y2K2 | |
| PQQASSSGPPNHHSQ | 231 | Q9NT68 | |
| SFHQPNNTPFPLSPN | 176 | Q99717 | |
| FQQPNSHPFPHSPNS | 176 | Q15797 | |
| TEPLTPHQPNHQPSF | 1931 | Q8NFU7 | |
| PHQPNHQPSFLTSPQ | 1936 | Q8NFU7 | |
| HPHPPQEPSADKNNN | 221 | Q6ZVT6 | |
| PSTPASAQASPHHQP | 376 | Q5JTD0 | |
| SAQASPHHQPSPAPL | 381 | Q5JTD0 | |
| APQSQPHDFVFSPHN | 566 | Q15468 | |
| SSHSNPPESNPDPVH | 741 | P38435 | |
| FIRGPPHHASNPNSP | 411 | A7XYQ1 | |
| SNSFPPPYHTASQPN | 196 | O14795 | |
| PNPPSTHFASQNQHS | 76 | Q5H9I0 | |
| NEASSNPSGHHPLPP | 481 | Q8WYQ9 | |
| RQPPQAAPSSHPHSD | 991 | Q9ULJ6 |